Ulcerative Colitis Clinical Trials near Chicago, IL
20 studies for Ulcerative Colitis are recruiting at 36 sites within 50 miles of Chicago, Illinois, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Ulcerative Colitis trials in the US or all trials near Chicago.
Recruiting now
Ulcerative Colitis studies enrolling near Chicago
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07184996
- Phase 3
- Ages 16 to 80 years
- Sex: All
Nearest sites: Rush University Medical Center - Site Number: 8400015 (Chicago, IL); GI Alliance - Glenview - Site Number: 8400068 (Glenview, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
NCT06398626
- Observational
- Ages 18 to 64 years
- Sex: All
Nearest sites: Feinberg School of Medicine Northwestern University (Chicago, IL); Rush University Medical Center (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
NCT05230173
- Interventional
- Ages 18 years and older
- Sex: All
Nearest site: University of Chicago Medicine (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
NCT05287126
- Phase 2
- Ages 12 to 17 years
- Sex: All
Nearest site: University of Chicago Medical Center (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
NCT06095128
- Phase 4
- Ages 18 to 65 years
- Sex: All
Nearest site: University of Chicago Medicine (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
NCT06693310
- Interventional
- Ages 18 to 75 years
- Sex: All
Nearest site: University of Chicago (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
NCT06937086
- Phase 3
- Ages 18 to 70 years
- Sex: All
Nearest site: Rush University Medical Center (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
NCT06979336
- Phase 2
- Ages 18 years and older
- Sex: All
Nearest site: University of Chicago Medical Center (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Site 038 (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
NCT07071519
- Phase 3
- Ages 2 to 17 years
- Sex: All
Nearest site: University of Chicago Medical Center /ID# 271588 (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
NCT07427017
- Phase 2
- Ages 18 to 85 years
- Sex: All
Nearest site: Northwestern University (Chicago, IL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
NCT06581328
- Phase 4
- Ages 18 to 80 years
- Sex: All
Nearest sites: GI Partners of Illinois - Southwest Gastroenterology (Oak Lawn, IL); GI Alliance - Glenview (Glenview, IL)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
NCT07697456
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest sites: Southwest Gastroenterology - Oak Lawn /ID# 280841 (Oak Lawn, IL); Gi Alliance - Glenview /ID# 283932 (Glenview, IL)
- Distance to nearest recruiting site
- ~11 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
NCT05442567
- Phase 3
- Ages 2 years and older
- Sex: All
Nearest site: Advocate Children's Hospital - Park Ridge - PIN (Park Ridge, IL)
- Distance to nearest recruiting site
- ~15 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
NCT07186101
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest sites: GI Alliance - Glenview (Glenview, IL); Midtown Gastroenterology and Liver Disease (Des Plaines, IL)
- Distance to nearest recruiting site
- ~17 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07845487
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest sites: Site US-007 (Glenview, IL); Site US-005 (Des Plaines, IL)
- Distance to nearest recruiting site
- ~17 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
NCT07113522
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest sites: Mirador Therapeutics Selected Site (Glenview, IL); Mirador Therapeutics Selected Site (Gurnee, IL)
- Distance to nearest recruiting site
- ~17 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest site: Midwest Digestive Health & Nutrition (Des Plaines, IL)
- Distance to nearest recruiting site
- ~17 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
NCT05987852
- Interventional
- Ages 18 to 85 years
- Sex: All
Nearest site: Northwestern Medicine Lake Forest Hospital (Lake Forest, IL)
- Distance to nearest recruiting site
- ~30 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
NCT06636656
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest site: Illinois Gastroenterology Group - Gurnee (Gurnee, IL)
- Distance to nearest recruiting site
- ~38 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining an Ulcerative Colitis clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.